This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Alzheimer's Disease Genetics Study (NCRAD)

This study is currently recruiting participants.
See Contacts and Locations
Verified November 2016 by Tatiana Foroud, Indiana University
National Institute on Aging (NIA)
Information provided by (Responsible Party):
Tatiana Foroud, Indiana University Identifier:
First received: July 14, 2003
Last updated: November 4, 2016
Last verified: November 2016
The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.

Alzheimer Disease Late Onset Alzheimer Disease Dementia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: National Cell Repository for Alzheimer's Disease (NCRAD)

Resource links provided by NLM:

Further study details as provided by Tatiana Foroud, Indiana University:

Primary Outcome Measures:
  • Distribute biological specimens to qualified investigators for use in their research studies. [ Time Frame: Contact investigators annually for an update on progress and publication status. ]
    Investigators will analyze the samples and publish de-identified results. These publications will help to further the knowledge in the field of dementia and potentially lead to new therapies and targets for therapies.

Biospecimen Retention:   Samples With DNA
blood samples

Estimated Enrollment: 3000
Study Start Date: June 2002
Estimated Study Completion Date: July 2021
Estimated Primary Completion Date: July 2021 (Final data collection date for primary outcome measure)
Detailed Description:
The purpose of the Alzheimer's Disease Genetics Study is to help identify the genes that may be responsible for causing Alzheimer's Disease (AD) by collecting genetic material from families with multiple members diagnosed with AD. Qualifying families will have two living blood-related individuals who have been diagnosed with or are showing symptoms of AD or dementia. Local study sites are located all over the United States, and arrangements may be made for eligible families who do not live near a participating site. The biological samples and data from these families will be made available to qualified researchers, who must sign a Materials Transfer Agreement (MTA) in order to protect the privacy rights of study participants before receiving DNA and data.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Families with two or more members with Alzheimer's disease or dementia

Inclusion Criteria:

  • Two living family members diagnosed with AD or other dementia with any age of onset
  • Biological samples available

    • Fresh blood, or
    • Immortalized lymphoblastic cell lines, or
    • 3-5 grams of frozen cerebral cortex; fixed samples are not accepted

Please note: this study does not include genetic counseling; because no personal identifying information such as name or date of birth is attached to samples, results of individual tests are not available to participants or family members.

Exclusion Criteria:

  • Does not meet inclusion criteria
  • Member of a family that was included in the National Institute of Mental Health AD Genetics Sib Pair collection
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00064870

Contact: Study Coordinator 1-800-526-2839

United States, Indiana
Participants are being recruited from all over the United States Recruiting
Nationwide, Indiana, United States, 46202
Contact: NCRAD Study Coordinator    800-526-2839   
Sponsors and Collaborators
Indiana University
National Institute on Aging (NIA)
Principal Investigator: Tatiana M. Foroud, PhD National Cell Repository for Alzheimer's Disease (NCRAD), Indiana University
  More Information

Additional Information:
Responsible Party: Tatiana Foroud, Department Chair, Indiana University Identifier: NCT00064870     History of Changes
Other Study ID Numbers: IA0042
U24AG021886 ( U.S. NIH Grant/Contract )
NIH grant U24 AG21886
Study First Received: July 14, 2003
Last Updated: November 4, 2016

Keywords provided by Tatiana Foroud, Indiana University:
Alzheimer disease
Late Onset Alzheimer disease risk factor genes

Additional relevant MeSH terms:
Alzheimer Disease
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders processed this record on September 21, 2017